Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

COVID-19 In Vitro Diagnostic Medical Device - detail

COVID-19 Hybrid Capture Fluorescence Immunoassay Test

Manufactured by Anbio (Xiamen) Biotechnology Co. Ltd., China - www.anbio.com 

Device identification number
32
CE Marking
×No
HSC common list (RAT)
×No
Format
Near POC / POC
Target type
Antibody
Specimen
Whole blood
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Assay Type
Immuno-Antibody
Reader Required
No
Method
Immunoassay
Measurement
Qualitative
Time
15 minutes
Detection Principle
Colorimetry
Notes
Automated lab-based, near-POC NAT or POC NAT card Colloidal Gold

The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements